Ascletis Pharma Inc./歌礼生物科技（杭州)有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Ganovo Enrolled in the Basic Medical Insurance of Tianjin--Capped Reimbursement-Per-Patient Pilot Program 2018-09-26 06:30
Ascletis Appoints Mr. Joshua Zhongbao Ling as VP Finance 2018-08-30 16:40
Ascletis' NDA for Its All-oral HCV Treatment Accepted by CFDA 2018-08-01 18:52
Ascletis Filed NDA for Its All-oral HCV Treatment 2018-07-31 20:43
Ganovo (R) Phase III Clinical Study Won the Top Award at the Infectious Disease National Congress of Chinese Medical Association 2018-07-30 17:42
Ascletis and CR Pharmaceutical Commercial Group Co., Ltd. Signed Strategic Cooperation Agreement 2018-06-26 16:39
1 5 6 7 8 9